Catalyst
Pit
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
☰
ARTV
Artiva Biotherapeutics, Inc.
NASDAQ · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Last close
$7.00
· 2026-10-07
ABOUT
Exchange
NASDAQ
Sector
Healthcare
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Market cap
$348.10M
Country
USA
RECENT INSIDER TRADES
2026-10-07
· Aslan Fred
(Chief Executive Officer)
· SELL
2026-10-06
· Aslan Fred
(Chief Executive Officer)
· SELL
2026-10-06
· Bush Jennifer
(COO, CLO, Compliance Officer)
· SELL
2026-10-06
· Horan Christopher
(Chief Tech Operations Officer)
· SELL
2026-10-06
· Banerjee Subhashis
(Chief Medical Officer)
· SELL
INSTITUTIONAL OWNERSHIP
Institutional holders
74
Shares held
40,639,059
Value
$392.65M
Percent of shares outstanding
83.12%
As of quarter end
2026-06-30
RECENT NEWS
Artiva Biotherapeutics Announces Multiple AlloNK® Data Presentations at the American College of Rheumatology (ACR) Convergence 2026
Artiva Biotherapeutics Highlights Updated AlloNK® Data in Sjögren Disease Presented at the 17th International Symposium on Sjögren’s Disease
Artiva Biotherapeutics at Stifel forum: nk cell therapy gains traction
Artiva Biotherapeutics presents AlloNK clinical data at Sjögren's disease symposium
Artiva Biotherapeutics to participate in Stifel immunology forum
Catalyst
Pit
Features
Coming soon
Pricing
Coming soon
Privacy
Terms
Disclaimer
Affiliate Terms
Contact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Artiva Biotherapeutics, Inc. (ARTV) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit